eCTD Granularity Best Practices: How to Structure Your FDA Submission Files

One of the most common questions we hear from teams preparing their first eCTD submission is: "How should we divide our content into separate files?" The answer has significant implications for reviewer experience, amendment efficiency, and long-term submission management.

At first glance, this appears to be a technical formatting decision. In reality, it is a structural decision guided by regulatory expectations that directly impact how efficiently the FDA can review your submission.

The ICH M8 eCTD Specification, FDA’s eCTD Technical Conformance Guide, and the M4 Common Technical Document (CTD) Guidance collectively provide a strong framework. They establish guardrails that help sponsors organize content in a way that supports consistency, clarity, and efficient navigation.

Within these guardrails, sponsors are not operating in a vacuum of choice. They are applying regulatory intent to ensure submissions are structured in a way that aligns with how reviewers access, interpret, and evaluate information.

While the guidances do not prescribe a single rigid file structure, they do provide clarity and direction.

The M4 CTD Annex V: Granularity Document and FDA electronic submission guidance outline expected levels of organization and document separation. These are designed to:

• Promote logical grouping of content

• Enable efficient navigation across modules

• Support lifecycle management of documents

  
  

Rather than offering unlimited flexibility, these guidances define a range of acceptable structures that balance usability, traceability, and maintainability.

What Is eCTD Granularity?

Granularity refers to how you divide your submission content into individual PDF files within the eCTD structure. Often, the same information can be organized as many small files, a few medium-sized files, or one large file. All may be technically compliant with eCTD specifications. While multiple configurations may be technically feasible, regulatory guidance helps shape what is appropriate by emphasizing three outcomes:

• Reviewability: Information should be organized so reviewers can quickly locate and assess content

• Maintainability: Updates should be manageable within the lifecycle of the submission

• Context: Related information should remain logically grouped to preserve meaning

  
  

According to FDA's Guidance on Providing Regulatory Submissions in Electronic Format, submissions should be organized to facilitate access to information, making granularity a key structural consideration rather than a purely tactical choice.

How Regulatory Guidance Supports Reviewer Efficiency 

The FDA reviewer opening your eCTD isn't starting from page one and reading straight through. They're navigating strategically, checking Module 2 summaries, jumping to specific Module 3 sections to verify claims, cross-referencing between modules, and often reviewing sections in parallel with other team members.

The purpose of the eCTD structure and associated granularity recommendations is to support these practices. When sponsors align with these guardrails:

• Information is organized in logical, reviewer-aligned units

• Related content is grouped and named appropriately

• Navigation becomes intuitive rather than burdensome

  
  

Granularity is not simply a sponsor preference. It is a mechanism for enabling efficient scientific review, grounded in regulatory expectations. Information is grouped in logical units that match review needs. Reviewers can access complete information on a topic without file-switching chaos. Related information stays together, providing context. And navigation is intuitive and efficient.

The goal is to organize the eCTD in a way that respects reviewer time and facilitates their evaluation of the science.

When Misalignment with Granularity Guidance Creates Challenges

Over-Granularization: How too many eCTD files slow FDA review

Over-granularization creates friction. A reviewer looking at numerous smaller files can lose context as they jump between documents. Instead of evaluating science, they spend cognitive energy managing files and the experience becomes tedious, which can affect review efficiency. While lifecycle flexibility may improve in some cases, excessive fragmentation can work against the goal of efficient review.

Under-Granularization: How large PDF files create eCTD submission challenges

Under-granularization creates different problems. In the case where a reviewer needs one page of a 600-page file, loading and navigating a massive file is very slow. Side-by-side comparison of related sections within the file becomes difficult, and any updates require reviewers to re-download and re-navigate enormous files.

Applying Granularity Guidance in Practice

Effective granularity reflects alignment with regulatory expectations while supporting real-world usability. The objective is not to maximize or minimize the number of files, but to structure content in accordance with eCTD-recommended document boundaries, grouping related information in a way that mirrors how it is reviewed while maintaining appropriate separation where distinct evaluation is required.

When implemented effectively, this approach enables reviewers to access complete topic areas efficiently and preserves context through logical organization.

eCTD Granularity and Amendments: Planning Your Submission Structure for Long-Term Maintenance

Your granularity decision today affects your submission management for years. Every amendment, every annual report, every supplement will work within the structure you establish in your initial submission.

Consider the impact of your update practices:

• Split the Quality Overall Summary (2.3) into separate files by subsection (e.g., 2.3.S Drug Substance summary vs. 2.3.P Drug Product summary) rather than submitting as one large document, making it easier for reviewers to locate specific quality information.

• Submit each drug substance manufacturer (3.2.S) as a separate granular section. If you have multiple API manufacturers or sites, keeping them separate allows you to update one site's information without touching the others. 

• Submit each analytical procedure and validation report in 3.2.P.5 separately by test method, allowing individual method updates without disturbing the full control section.

• Stability updates are ongoing. If stability data is scattered across dozens of files (e.g. separate files for each timepoint), every update becomes a tracking challenge. If it's consolidated appropriately, updates are straightforward.

  
  

Structure your initial submission with future maintenance in mind. Ask yourself: "When we need to update this information, how many files will we need to replace?" Reasonable numbers indicate good granularity. Extreme numbers suggest reconsidering your approach.

Summary

Granularity is one of those eCTD decisions that have significant practical implications. The ICH specifications and FDA guidance provide the framework, but they intentionally leave the specifics to sponsor judgment.

That judgment should be informed by three principles:

Think like a reviewer: How would you want information organized if you were evaluating this submission? Would your proposed structure help or hinder efficient review?

Plan for the lifecycle: This structure will persist through amendments and supplements. Will it support efficient updates, or create maintenance headaches?

Seek the middle ground: Both extremes, hundreds of tiny files or a few massive files, create problems. Strategic grouping that preserves context while maintaining logical separation typically works best.

Your granularity decisions will significantly impact the reviewer experience and how you maintain your submission. Taking a thoughtful, guidance-informed approach to these decisions helps establish a strong and sustainable foundation for your regulatory operations.

WAYS has helped numerous life sciences teams build and submit successful, reviewer-friendly submissions. If you're planning your first eCTD or need a strong submission partner, we're here to help. Contact us today!